Presbia PLC has completed an IPO in the amount of $41.67 million.

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. It operates through the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. Its microlens is a disc-shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia. The Company's solution is intended primarily for emmetropic-presbyopes, or those individuals who suffer from presbyopia but do not have any other visual disorder. The Company has its manufacturing capacity in Irvine, California.